Approach to residual dizziness after successfully treated benign paroxysmal positional vertigo: effect of a polyphenol compound supplementation
Rattachement africain : it. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
PURPOSE: ) could improve residual dizziness earlier after benign paroxysmal positional vertigo (BPPV) and relieve patients from this disabling symptomatology. METHODS: In this prospective, multicentric study, 127 patients were randomized in the treatment group (TG), who received a 60-day supplementation, while 131 patients were randomized in the control group (CG), who did not receive any medication. The dizziness handicap inventory (DHI) score, static posturography, and the visual analog scale (VAS) for both dizziness (D-VAS) and nausea/vomit (N/V-VAS) were used as measures of outcome at baseline and after 30 and 60 days. Patients were asked about efficacy and tolerance to the treatment. Side effects were examined. RESULTS: A statistically significant greater decrease was established in the TG for DHI, D-VAS, and N/V-VAS compared to the CG. On the other hand, static posturography did not show statistical differences between the two groups, though a better clinical improvement after 60-day supplementation was shown in the TG in comparison to the CG. We counted mild side effects in only 2 patients. Most patients reported an excellent or good efficacy and tolerance to the treatment. CONCLUSION: Residual dizziness is a frequent condition of unknown origin that manifests as persistent disabling imbalance after successful repositioning maneuvers for BPPV. The decreasing postural control can affect the quality of life, contributing to falling and psychological problems. The supplementation with the polyphenol compound used in our study is safe, manageable, and appeared to be able to reduce subjective symptoms and improve instability earlier, decreasing the risk of potential complications.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- <p>Approach to residual dizziness after successfully treated benign paroxysmal positional vertigo: effect of a polyphenol compound supplementation</p>
- Date Crossref
- 01/08/2019
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Pisa pays non établi dans la noticeUniversité ou école supérieure
-
University of Turin Department of Surgical Sciences pays non établi dans la noticeUniversité ou école supérieure
-
University of Cagliari pays non établi dans la noticeUniversité ou école supérieure
-
Ospedale Madonna Delle Grazie pays non établi dans la noticeÉtablissement de santé
-
Magna Graecia University pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedaliero-Universitaria "Renato Dulbecco" pays non établi dans la noticeÉtablissement de santé
-
University of Naples Federico II pays non établi dans la noticeUniversité ou école supérieure
-
Sapienza University of Rome Department of Sense Organs pays non établi dans la noticeUniversité ou école supérieure
-
San Raffaele University of Rome pays non établi dans la noticeUniversité ou école supérieure
-
Azienda Ospedaliera G.Rummo pays non établi dans la noticeÉtablissement de santé
-
Pisa University Department of Medical and Surgical Pathology pays non établi dans la noticeUniversité ou école supérieure
-
Otorhinolaryngology pays non établi dans la noticeOrganisation à but non lucratif
University of Pisa, Department of Surgical Sciences — University of Turin et University of Cagliari, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.